Literature DB >> 28271362

Mesothelioid reaction following talc pleurodesis: a case report.

Tatyana Faynberg1, Neha Patel1, Amrit P Nayar2, Alan J Shienbaum3,4.   

Abstract

INTRODUCTION: Talc pleurodesis is a well-established procedure performed to obliterate the pleural space to prevent recurrent pleural effusion and/or recurrent pneumothorax. Pleurodesis is commonly accomplished by draining the pleural fluid, if present, followed by either a mechanical procedure, such as abrasion, pleurectomy, or instillation of a chemical irritant into the pleural space, which results in inflammation and fibrosis which obliterates the pleural space. The reported complications of talc pleurodesis are hypoxemia, hypotension, tachycardia, dyspnea, chest pain, and fever. CASE
PRESENTATION: Herein, we present a case of a 43-year-old female patient who developed an intense mesothelioid reaction which occurred 7 years following talc pleurodesis.
CONCLUSION: This case represents a unique mesothelioid reaction which became manifested several years after recurrent talc pleurodesis. Such a mesothelioid reaction can clinically and radiographically mimic malignant mesothelioma. We conclude that Talc pleurodesis played a causative role in this patient developing an intense mesothelioid reaction. A mesothelioid reaction should be included in the differential diagnosis in patients with pleural thickening/pleural plaque formation who have previously been treated with talc pleurodesis.

Entities:  

Keywords:  Mesothelioid reaction; Mesothelioma; Pleurodesis; Talc

Mesh:

Substances:

Year:  2017        PMID: 28271362     DOI: 10.1007/s11748-017-0758-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

Review 1.  Talc should be used for pleurodesis.

Authors:  S A Sahn
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

Review 2.  Pneumothorax.

Authors:  Marc Noppen; Tom De Keukeleire
Journal:  Respiration       Date:  2008-06-26       Impact factor: 3.580

Review 3.  Talc pleurodesis for the treatment of pneumothorax and pleural effusion.

Authors:  L Kennedy; S A Sahn
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

Review 4.  Management of malignant pleural effusions: questions that need answers.

Authors:  Helen E Davies; Y C Gary Lee
Journal:  Curr Opin Pulm Med       Date:  2013-07       Impact factor: 3.155

5.  Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size.

Authors:  Nick A Maskell; Y C Gary Lee; Fergus V Gleeson; Emma L Hedley; Gerry Pengelly; Robert J O Davies
Journal:  Am J Respir Crit Care Med       Date:  2004-05-13       Impact factor: 21.405

Review 6.  Chemical pleurodesis for malignant pleural effusions.

Authors:  P B Walker-Renard; L M Vaughan; S A Sahn
Journal:  Ann Intern Med       Date:  1994-01-01       Impact factor: 25.391

7.  Acute inflammatory response secondary to intrapleural administration of two types of talc.

Authors:  V F Rossi; F S Vargas; E Marchi; M M P Acencio; E H Genofre; V L Capelozzi; L Antonangelo
Journal:  Eur Respir J       Date:  2009-08-13       Impact factor: 16.671

8.  Adult respiratory distress syndrome following intrapleural instillation of talc.

Authors:  J E Rinaldo; G R Owens; R M Rogers
Journal:  J Thorac Cardiovasc Surg       Date:  1983-04       Impact factor: 5.209

Review 9.  Inflammation and clinical repercussions of pleurodesis induced by intrapleural talc administration.

Authors:  Eduardo Henrique Genofre; Evaldo Marchi; Francisco S Vargas
Journal:  Clinics (Sao Paulo)       Date:  2007-10       Impact factor: 2.365

  9 in total
  1 in total

1.  Observational analysis on inflammatory reaction to talc pleurodesis: Small and large animal model series review.

Authors:  Jacopo Vannucci; Guido Bellezza; Alberto Matricardi; Giulia Moretti; Antonello Bufalari; Lucio Cagini; Francesco Puma; Niccolò Daddi
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.